New Markers in the Early Diagnosis and Prognostic Evaluation of Ovarian Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: closed (30 November 2022) | Viewed by 5913
Special Issue Editor
Special Issue Information
Dear Colleagues,
Gynecological cancers represent one of the leading causes of cancer-related deaths in women. Compared to other types of cancer, gynecological cancers are uncommon, but their incidence is increasing, likely attributable to the aging of populations and increased prevalence of obesity in the developed world. The main types of gynecological cancer that affect a woman's reproductive organs are cervical, ovarian, uterine, vaginal, and vulvar tumors. The mainstay of treatment for gynecological cancer includes multimodal therapy with optimal surgery, chemotherapy, and radiotherapy. The introduction of effective screening methods and efforts to achieve early diagnoses will allow improving the outcomes of these patients. In recent years, the introduction of innovative diagnostic methods and innovative surgical, as well as medical, treatments have improved early detection and the outcomes for gynecological cancer patients. The objective of the current Special Issue in Cancers is to publish original research papers and reviews from authors who are interested in addressing these challenges and provide new insights and novel treatment strategies for patients with gynecological cancer.
Dr. Francesco Raspagliesi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gynecological cancers
- early detection
- novel treatment strategies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
